» Articles » PMID: 35246267

Circular RNA Detection Identifies CircPSEN1 Alterations in Brain Specific to Autosomal Dominant Alzheimer's Disease

Abstract

Background: Autosomal-dominant Alzheimer's disease (ADAD) is caused by pathogenic mutations in APP, PSEN1, and PSEN2, which usually lead to an early age at onset (< 65). Circular RNAs are a family of non-coding RNAs highly expressed in the nervous system and especially in synapses. We aimed to investigate differences in brain gene expression of linear and circular transcripts from the three ADAD genes in controls, sporadic AD, and ADAD.

Methods: We obtained and sequenced RNA from brain cortex using standard protocols. Linear counts were obtained using the TOPMed pipeline; circular counts, using python package DCC. After stringent quality control (QC), we obtained the counts for PSEN1, PSEN2 and APP genes. Only circPSEN1 passed QC. We used DESeq2 to compare the counts across groups, correcting for biological and technical variables. Finally, we performed in-silico functional analyses using the Circular RNA interactome website and DIANA mirPath software.

Results: Our results show significant differences in gene counts of circPSEN1 in ADAD individuals, when compared to sporadic AD and controls (ADAD = 21, AD = 253, Controls = 23-ADADvsCO: logFC = 0.794, p = 1.63 × 10, ADADvsAD: logFC = 0.602, p = 8.22 × 10). The high gene counts are contributed by two circPSEN1 species (hsa_circ_0008521 and hsa_circ_0003848). No significant differences were observed in linear PSEN1 gene expression between cases and controls, indicating that this finding is specific to the circular forms. In addition, the high circPSEN1 levels do not seem to be specific to PSEN1 mutation carriers; the counts are also elevated in APP and PSEN2 mutation carriers. In-silico functional analyses suggest that circPSEN1 is involved in several pathways such as axon guidance (p = 3.39 × 10), hippo signaling pathway (p = 7.38 × 10), lysine degradation (p = 2.48 × 10) or Wnt signaling pathway (p = 5.58 × 10) among other KEGG pathways. Additionally, circPSEN1 counts were able to discriminate ADAD from sporadic AD and controls with an AUC above 0.70.

Conclusions: Our findings show the differential expression of circPSEN1 is increased in ADAD. Given the biological function previously ascribed to circular RNAs and the results of our in-silico analyses, we hypothesize that this finding might be related to neuroinflammatory events that lead or that are caused by the accumulation of amyloid-beta.

Citing Articles

Circular RNAs in neurological conditions - computational identification, functional validation, and potential clinical applications.

Hatzimanolis O, Sykes A, Cristino A Mol Psychiatry. 2025; .

PMID: 39966624 DOI: 10.1038/s41380-025-02925-1.


RNA dysregulation in neurodegenerative diseases.

Li Y, Sun S EMBO J. 2025; 44(3):613-638.

PMID: 39789319 PMC: 11790913. DOI: 10.1038/s44318-024-00352-6.


Quantitative Real-Time PCR for Circular RNA Detection and Analysis.

Rai A, Garikipati V Methods Mol Biol. 2024; 2894:133-141.

PMID: 39699815 DOI: 10.1007/978-1-0716-4342-6_11.


Circulating blood circular RNA in Parkinson's Disease; from involvement in pathology to diagnostic tools in at-risk individuals.

Beric A, Sun Y, Sanchez S, Martin C, Powell T, Kumar R NPJ Parkinsons Dis. 2024; 10(1):222.

PMID: 39557914 PMC: 11574145. DOI: 10.1038/s41531-024-00839-3.


15 Years of Longitudinal Genetic, Clinical, Cognitive, Imaging, and Biochemical Measures in DIAN.

Daniels A, McDade E, Llibre-Guerra J, Xiong C, Perrin R, Ibanez L medRxiv. 2024; .

PMID: 39148846 PMC: 11326320. DOI: 10.1101/2024.08.08.24311689.


References
1.
Ashwal-Fluss R, Meyer M, Pamudurti N, Ivanov A, Bartok O, Hanan M . circRNA biogenesis competes with pre-mRNA splicing. Mol Cell. 2014; 56(1):55-66. DOI: 10.1016/j.molcel.2014.08.019. View

2.
Wang R, Zhang J . Clinical significance of miR-433 in the diagnosis of Alzheimer's disease and its effect on Aβ-induced neurotoxicity by regulating JAK2. Exp Gerontol. 2020; 141:111080. DOI: 10.1016/j.exger.2020.111080. View

3.
Ryan N, Nicholas J, Weston P, Liang Y, Lashley T, Guerreiro R . Clinical phenotype and genetic associations in autosomal dominant familial Alzheimer's disease: a case series. Lancet Neurol. 2016; 15(13):1326-1335. DOI: 10.1016/S1474-4422(16)30193-4. View

4.
Mehta S, Dempsey R, Vemuganti R . Role of circular RNAs in brain development and CNS diseases. Prog Neurobiol. 2020; 186:101746. PMC: 7024016. DOI: 10.1016/j.pneurobio.2020.101746. View

5.
Wang L, Nie J, Sicotte H, Li Y, Eckel-Passow J, Dasari S . Measure transcript integrity using RNA-seq data. BMC Bioinformatics. 2016; 17:58. PMC: 4739097. DOI: 10.1186/s12859-016-0922-z. View